Tumor-microenvironment-adaptive EIMSeO-IR783 peptide nanophotothermal agent synergizes with STING agonist for enhanced cancer immunotherapy.
A Tumor-Microenvironment-Adaptive Peptide-Based Nanophotothermal Agent for Synergistic Photothermal-Immunotherapy.
Abstract
EIMSeO-IR783 nanophotothermal agent adapts to the tumor microenvironment, enhancing photothermal therapy and synergizing with a STING agonist for anti-cancer immunity.